Navigation Links
Early Bird Offers on Healthcare and Biotechnology Conferences, Save Up To 20% by Registering with Global Information
Date:6/7/2012

FARMINGTON, Conn., June 5, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce limited available early bird discounted registration for three important international healthcare and biotechnology conferences:

PEGS Europe - Protein & Antibody Engineering Summit 2012

November 6 – 8, 2012 – Vienna, Austria – The Fourth Annual Protein & Antibody Engineering Summit (PEGS Europe) presents an exciting opportunity to hear from leaders in the fields of novel biotherapeutics and protein expression. Each program also brings together conference participants from diverse backgrounds and experiences through unique interactive, topic-themed roundtable discussions.

This year's 2-part, 3-day conference will feature four programs: Enhancing Expression & Achieving Higher Throughput; Engineering of Novel Antibody Constructs & Alternative Scaffolds; Solving Difficult Protein Problems; and Therapeutic Developments with Novel Antibody Products.

Lowest priced Early Bird registration ends next month! Save up to $580 by registering before July 27 at http://www.giiconference.com/chi229588-2012/

American Health Care Congress

November 12 – 13, 2012 – Anaheim, CA, USA - The 9th Annual American Health Care Congress (AHCC) is an intensive, two-day educational and networking forum, designed for senior health care executives and key decision makers from the nation's leading hospitals, health systems, health plans and medical groups focused on driving innovation, collaboration and quality and cost improvements post-reform. The agenda is dedicated to bringing the health care community together to discuss strategies to decrease the cost of care, drive delivery innovation, develop aligned incentives, redesign effective operations and leverage health care IT. By convening over 400 diverse thought leaders, AHCC identifies innovative delivery models and integration strategies to improve the overall delivery of health care and the critical steps to adapt our health system to operate more efficiently post health reform.

Register early and save up to $360 by September 28, 2012 at http://www.giiconference.com/woco224414-2012/

Leaders in Biobanking Congress 2012

October 1 – 2, 2012 – Chapel Hill, NC, USA – The 4th Annual Leaders in Biobanking Congress addresses both the business and science of biobanking. The conference brings together biomedical and biopharmaceutical researchers, regulators, biorepository managers and practitioners to investigate the best tactics for effective use of biospecimens within today's cutting edge research.

Attendees will gain insight from biobanking managers and biopreservation scientists and delve into the molecular advances in biomedical science; Determine best practices in biopreservation protocols through panel discussions; use case studies to analyze ongoing biobanking partnerships; attend interactive short courses; join discussion groups and network.

Attendees save $450 with Limited time Early Bird discount ending June 22, register at http://www.giiconference.com/woco224422-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. Early Bird Discounts Available on International Healthcare and Biotechnology Conferences, Save Up To $600 with Global Information
2. Clinical trials for Alzheimers disease preventative drug to begin early 2013
3. Nearly one-tenth of hemispheres mammals unlikely to outrun climate change
4. Begin early: Researchers say water with meals may encourage wiser choices
5. Study: Men who do load-bearing exercise in early 20s may be shielded from osteoporosis
6. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
7. New study links air pollution and early death in the UK
8. Early detection techniques offer hope for improved outcomes in lung cancer patients
9. Promising developments in early diagnosis and treatment of mesothelioma
10. A new gene thought to be the cause in early-onset forms of Alzheimers disease
11. Early warning system for seizures could cut false alarms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/16/2017)... March 16, 2017 CeBIT 2017 - Against identity fraud with DERMALOG ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution ... Used combined in one ... ...
(Date:3/7/2017)... , March 7, 2017   HireVue , ... top global companies identify the best talent, faster, today ... Chief Sales Officer (CSO) and Diana Kucer ... round out a seasoned executive team poised to drive continued ... building on a year of record bookings in 2017. ...
(Date:3/2/2017)... 2, 2017 Australian stem cell and regenerative ... has signed an agreement with the Monash Lung Biology ... Discovery Institute and Department of Pharmacology at Monash University, ... preclinical study to support the use of Cymerus™ mesenchymal ... Asthma is a chronic, long term lung ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017 Kineta, Inc., ... of novel therapies in immuno-oncology, today announced the ... small molecule compounds that activate interferon response factor ... and demonstrate immune-mediated tumor regression in a murine ... study who demonstrated complete tumor regression to initial ...
(Date:3/23/2017)... March 23, 2017 In today,s ... equities in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: ... (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market ... free report at: ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
(Date:3/22/2017)... LEXINGTON, Mass. , March 22, 2017   ... collections, today announced that Doctors Pathology Service ... mid-Atlantic region of the United States ... the Delaware Health Information Network (DHIN) to ... researchers. The novel program, announced in ...
Breaking Biology Technology: